---
title: "Barclays Remains a Sell on Allianz (0M6S)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286228405.md"
description: "Barclays analyst Claudia Gaspari maintained a Sell rating on Allianz today and set a price target of €350.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Gaspari is ranked #1605 out of 12188 analysts. Currently, the analyst consensus on Allianz is a Hold with an average price target of €400.98."
datetime: "2026-05-13T09:02:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286228405.md)
  - [en](https://longbridge.com/en/news/286228405.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286228405.md)
---

# Barclays Remains a Sell on Allianz (0M6S)

Barclays analyst Claudia Gaspari maintained a Sell rating on Allianz today and set a price target of €350.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Gaspari is ranked #1605 out of 12188 analysts.

Currently, the analyst consensus on Allianz is a Hold with an average price target of €400.98.

### Related Stocks

- [ALIZY.US](https://longbridge.com/en/quote/ALIZY.US.md)
- [ALV.DE](https://longbridge.com/en/quote/ALV.DE.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Jefferies Remains a Hold on Allianz (0M6S)](https://longbridge.com/en/news/286216137.md)
- [Berenberg Bank Sticks to Its Buy Rating for Allianz SE Unsponsored ADR (ALIZY)](https://longbridge.com/en/news/273694672.md)
- [Are Wall Street Analysts Bullish on Akamai Technologies Stock?](https://longbridge.com/en/news/286949319.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)